101 West Main Street, Pipestone, MN 56164 | Phone: (507) 825-3100 | Fax: (507) 825-5810 | Mon-Fri 8:30am - 5:30pm | Sat 8:30am - 3:00pm | Sun Closed

Get Healthy!

  • Posted June 9, 2026

New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy

Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.

Health News is provided as a service to A and S Drugs site users by HealthDay. A and S Drugs nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.
Copyright © 2026 HealthDay All Rights Reserved.

Share

Tags